针对我国中成药品种混乱,同方异名、同名异方、同方而功能主治相差甚远或组方不合理、疗效不确切的问题,国家药品监督管理局强调,将组织力量依法解决没有收入国家标准管理的地方标准中成药问题,解决中成药品种重复申报,低水平重复生产的问题。从2003年1月1日起,地方标准品种将 Concerning the disorder of Chinese proprietary Chinese medicines, with the exception of synonyms, names, synonyms, and functions of the same party, or the problem of unreasonable and inaccurate results, the State Drug Administration stressed that it will organize forces to resolve national standards without income according to law. Management of local standards for proprietary Chinese medicines, the issue of repetitive application of proprietary Chinese medicines, and low level of repeated production. From January 1, 2003, local standard varieties will